Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization

ABSTRACT As a consequence of their independent evolutionary origins in apes and Old World monkeys, human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency viruses of the SIVsmm/mac lineage express phylogenetically and antigenically distinct envelope glycoproteins. Thus, HIV-1 Env-spe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Benjamin von Bredow, Raiees Andrabi, Michael Grunst, Andres G. Grandea, Khoa Le, Ge Song, Zachary T. Berndsen, Katelyn Porter, Jesper Pallesen, Andrew B. Ward, Dennis R. Burton, David T. Evans
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://doaj.org/article/c1a57cf58e484610983b2c42b864ce7c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c1a57cf58e484610983b2c42b864ce7c
record_format dspace
spelling oai:doaj.org-article:c1a57cf58e484610983b2c42b864ce7c2021-11-15T16:22:10ZDifferences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization10.1128/mBio.01255-192150-7511https://doaj.org/article/c1a57cf58e484610983b2c42b864ce7c2019-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01255-19https://doaj.org/toc/2150-7511ABSTRACT As a consequence of their independent evolutionary origins in apes and Old World monkeys, human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency viruses of the SIVsmm/mac lineage express phylogenetically and antigenically distinct envelope glycoproteins. Thus, HIV-1 Env-specific antibodies do not typically cross-react with the Env proteins of SIVsmm/mac isolates. Here we show that PGT145, a broadly neutralizing antibody to a quaternary epitope at the V2 apex of HIV-1 Env, directs the lysis of SIVsmm/mac-infected cells by antibody-dependent cellular cytotoxicity (ADCC) but does not neutralize SIVsmm/mac infectivity. Amino acid substitutions in the V2 loop of SIVmac239 corresponding to the epitope for PGT145 in HIV-1 Env modulate sensitivity to this antibody. Whereas a substitution in a conserved N-linked glycosylation site (N171Q) eliminates sensitivity to ADCC, a lysine-to-serine substitution in this region (K180S) increases ADCC and renders the virus susceptible to neutralization. These differences in function correlate with an increase in the affinity of PGT145 binding to Env on the surface of virus-infected cells and to soluble Env trimers. To our knowledge, this represents the first instance of an HIV-1 Env-specific antibody that cross-reacts with SIVsmm/mac Env and illustrates how differences in antibody binding affinity for Env can differentiate sensitivity to ADCC from neutralization. IMPORTANCE Here we show that PGT145, a potent broadly neutralizing antibody to HIV-1, directs the lysis of SIV-infected cells by antibody-dependent cellular cytotoxicity but does not neutralize SIV infectivity. This represents the first instance of cross-reactivity of an HIV-1 Env-specific antibody with SIVsmm/mac Env and reveals that antibody binding affinity can differentiate sensitivity to ADCC from neutralization.Benjamin von BredowRaiees AndrabiMichael GrunstAndres G. GrandeaKhoa LeGe SongZachary T. BerndsenKatelyn PorterJesper PallesenAndrew B. WardDennis R. BurtonDavid T. EvansAmerican Society for MicrobiologyarticleADCCantibody functionhuman immunodeficiency virusneutralizing antibodiessimian immunodeficiency virusMicrobiologyQR1-502ENmBio, Vol 10, Iss 4 (2019)
institution DOAJ
collection DOAJ
language EN
topic ADCC
antibody function
human immunodeficiency virus
neutralizing antibodies
simian immunodeficiency virus
Microbiology
QR1-502
spellingShingle ADCC
antibody function
human immunodeficiency virus
neutralizing antibodies
simian immunodeficiency virus
Microbiology
QR1-502
Benjamin von Bredow
Raiees Andrabi
Michael Grunst
Andres G. Grandea
Khoa Le
Ge Song
Zachary T. Berndsen
Katelyn Porter
Jesper Pallesen
Andrew B. Ward
Dennis R. Burton
David T. Evans
Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization
description ABSTRACT As a consequence of their independent evolutionary origins in apes and Old World monkeys, human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency viruses of the SIVsmm/mac lineage express phylogenetically and antigenically distinct envelope glycoproteins. Thus, HIV-1 Env-specific antibodies do not typically cross-react with the Env proteins of SIVsmm/mac isolates. Here we show that PGT145, a broadly neutralizing antibody to a quaternary epitope at the V2 apex of HIV-1 Env, directs the lysis of SIVsmm/mac-infected cells by antibody-dependent cellular cytotoxicity (ADCC) but does not neutralize SIVsmm/mac infectivity. Amino acid substitutions in the V2 loop of SIVmac239 corresponding to the epitope for PGT145 in HIV-1 Env modulate sensitivity to this antibody. Whereas a substitution in a conserved N-linked glycosylation site (N171Q) eliminates sensitivity to ADCC, a lysine-to-serine substitution in this region (K180S) increases ADCC and renders the virus susceptible to neutralization. These differences in function correlate with an increase in the affinity of PGT145 binding to Env on the surface of virus-infected cells and to soluble Env trimers. To our knowledge, this represents the first instance of an HIV-1 Env-specific antibody that cross-reacts with SIVsmm/mac Env and illustrates how differences in antibody binding affinity for Env can differentiate sensitivity to ADCC from neutralization. IMPORTANCE Here we show that PGT145, a potent broadly neutralizing antibody to HIV-1, directs the lysis of SIV-infected cells by antibody-dependent cellular cytotoxicity but does not neutralize SIV infectivity. This represents the first instance of cross-reactivity of an HIV-1 Env-specific antibody with SIVsmm/mac Env and reveals that antibody binding affinity can differentiate sensitivity to ADCC from neutralization.
format article
author Benjamin von Bredow
Raiees Andrabi
Michael Grunst
Andres G. Grandea
Khoa Le
Ge Song
Zachary T. Berndsen
Katelyn Porter
Jesper Pallesen
Andrew B. Ward
Dennis R. Burton
David T. Evans
author_facet Benjamin von Bredow
Raiees Andrabi
Michael Grunst
Andres G. Grandea
Khoa Le
Ge Song
Zachary T. Berndsen
Katelyn Porter
Jesper Pallesen
Andrew B. Ward
Dennis R. Burton
David T. Evans
author_sort Benjamin von Bredow
title Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization
title_short Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization
title_full Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization
title_fullStr Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization
title_full_unstemmed Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV<sub>smm/mac</sub> Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization
title_sort differences in the binding affinity of an hiv-1 v2 apex-specific antibody for the siv<sub>smm/mac</sub> envelope glycoprotein uncouple antibody-dependent cellular cytotoxicity from neutralization
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/c1a57cf58e484610983b2c42b864ce7c
work_keys_str_mv AT benjaminvonbredow differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT raieesandrabi differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT michaelgrunst differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT andresggrandea differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT khoale differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT gesong differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT zacharytberndsen differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT katelynporter differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT jesperpallesen differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT andrewbward differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT dennisrburton differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
AT davidtevans differencesinthebindingaffinityofanhiv1v2apexspecificantibodyforthesivsubsmmmacsubenvelopeglycoproteinuncoupleantibodydependentcellularcytotoxicityfromneutralization
_version_ 1718426929273503744